Numerous studies have shown that IL-6 is overexpressed not only in cancerous tissues but also in the sera of patients with different malignancies, such as lung cancer, multiple myeloma, leukemia, gastric cancer, and colon cancer. Here, IL6 is linked to plasma cell myeloma.